Solubility measurement and thermodynamic properties of Nintedanib Esylate Hemihydrate in pure solvents

被引:18
作者
Ma, Jinju [1 ,2 ]
Huang, Jingyi [1 ]
Cao, Zidan [1 ]
Sha, Jiao [1 ]
Sun, Renren [1 ]
He, Haixia [1 ]
Wan, Yameng [1 ]
Li, Yu [1 ]
Li, Tao [1 ]
Ren, Baozeng [1 ]
机构
[1] Zhengzhou Univ, Sch Chem Engn, Zhengzhou 450001, Henan, Peoples R China
[2] Yellow River Conservancy Tech Inst, Sch Environm Engn, Kaifeng 475004, Henan, Peoples R China
关键词
Nintedanib Esylate Hemihydrate; Thermodynamic properties; Molecular dynamics simulation; Thermodynamic models; MOLECULAR-DYNAMICS SIMULATION; RADIAL-DISTRIBUTION FUNCTION; PARAMETERS; REPRESENTATION; MIXTURES; WATER; ACID;
D O I
10.1016/j.molliq.2022.118624
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The thermodynamic property of NE crystallization in 10 pure solvents was studied, and the solid-liquid equilibrium solubility of NE in these ten solvents was determined by laser dynamic method. The result showed that the solubility was proportional to the temperature. Five models including the modified Apleblat model, kh model, Polynomial model, Van't Hoff model, and Yaws model were adopted to fit the solubility of the solute in a single solvent, and the result showed that the Polynomial model had a high fitting degree for the solubility of NE in the single solvent chosen. The activity coefficients, as well as thermodynamic properties of the mixing, were obtained and studied. The effect of solvents themselves on the solubility order of Nintedanib Esylate was also studied by correlating to the solubility of Nintedanib Esylate through the KAT-LSER model. What is more, by adopting Molecular Dynamic simulation, it was proved that the Nintedanib Esylate solubility in different solvents could be largely influenced by the interaction of the solute molecules and solvent molecules. (C) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数:17
相关论文
共 54 条
[2]   MODEL FOR SOLUBILITY ESTIMATION IN MIXED-SOLVENT SYSTEMS [J].
BARZEGARJALALI, M ;
HANAEE, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 109 (03) :291-295
[3]  
BASF Schweiz AG, 1946, GB. Pat. Appl., Patent No. [GB608295A, 608295]
[4]   Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib [J].
Bonella, Francesco ;
Stowasser, Susanne ;
Wollin, Lutz .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :6407-6419
[5]   SOLVENT ACTIVITY ALONG A SATURATION LINE AND SOLUBILITY OF HYDROGEN-BONDING SOLIDS [J].
BUCHOWSKI, H ;
KSIAZCZAK, A ;
PIETRZYK, S .
JOURNAL OF PHYSICAL CHEMISTRY, 1980, 84 (09) :975-979
[6]   OLEX2: a complete structure solution, refinement and analysis program [J].
Dolomanov, Oleg V. ;
Bourhis, Luc J. ;
Gildea, Richard J. ;
Howard, Judith A. K. ;
Puschmann, Horst .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2009, 42 :339-341
[7]   Correlation and thermodynamic analysis of solubility of diphenhydramine hydrochloride in pure and binary solvents [J].
Du, Shichao ;
Wang, Yan ;
Li, Jianyu ;
Wu, Songgu ;
Dun, Weiqiang ;
Song, Xiaopeng ;
Wang, Jingkang ;
Gong, Junbo .
JOURNAL OF CHEMICAL THERMODYNAMICS, 2016, 93 :132-142
[8]   MOLECULAR-DYNAMICS SIMULATION OF VAPOR-DEPOSITED AMORPHOUS ICE [J].
ESSMANN, U ;
GEIGER, A .
JOURNAL OF CHEMICAL PHYSICS, 1995, 103 (11) :4678-4692
[9]   METHOD FOR ESTIMATING BOTH SOLUBILITY PARAMETERS AND MOLAR VOLUMES OF LIQUIDS [J].
FEDORS, RF .
POLYMER ENGINEERING AND SCIENCE, 1974, 14 (02) :147-154
[10]   Nintedanib in Progressive Fibrosing Interstitial Lung Diseases [J].
Flaherty, K. R. ;
Wells, A. U. ;
Cottin, V ;
Devaraj, A. ;
Walsh, S. L. F. ;
Inoue, Y. ;
Richeldi, L. ;
Kolb, M. ;
Tetzlaff, K. ;
Stowasser, S. ;
Coeck, C. ;
Clerisme-Beaty, E. ;
Rosenstock, B. ;
Quaresma, M. ;
Haeufel, T. ;
Goeldner, R-G ;
Schlenker-Herceg, R. ;
Brown, K. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) :1718-1727